External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Neuroscience ADPD 2021
Roche and Genentech at

ADPD 2021

March 09 - March 14
Virtual
adpd.kenes.com
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
09:15 AM
Duration 15mins Virtual
Utilisation of home nursing to mitigate the impact of COVID-19 on the conduct of the gantenerumab graduate trials
Searle A, Thanasopoulou A, Kenton J, Voyle N, Thorne N, Baudler M, Doody R, Kerchner GA
Neuroscience | Alzheimer Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
12:15 PM
Duration 15mins Virtual
Translation of RG6102, an amyloid-targeting therapy with superior brain penetration properties, to the clinic
Kulic L, Hofmann C, Janssen N, Grimm HP, Abrantes J, Schumacher V, Marchesi M, Niewöhner J, Svoboda H
Neuroscience | Alzheimer Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
09:00 AM
Duration 15mins Virtual
A Phase II study to evaluate the safety and efficacy of prasinezumab in early Parkinson's disease (PASADENA): Results from Part 1 Week 52
Gennaro Pagano, F Boess K.I Taylor B Mollenhauer W Poewe, M Marchesi, A Boulay, J Anzures-Cabrera, A Vogt, T Nikolcheva, W Zago, R Tripuraneni, D.K Ness, H Svoboda, M Britschgi, R Doody, P Fontoura, D Umbricht, and A Bonni for the Prasinezumab Study Group
Neuroscience | Parkinson's Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
09:15 AM
Duration 15mins Virtual
Roche PD Mobile Application v2 Detects Slowing of Early Parkinson’s Disease Progression under Prasinezumab: PASADENA Phase II Part 1 Results
Kirsten I. Taylor, Florian Lipsmeier, Ekaterina Volkova-Volkmar, Daria Rukina, Judith Anzures Cabrera, Laurent Essioux, Markus Abt, Ben van Lier , Alessandra E. Thomann, Hanno Svoboda, Wagner Zago, Gennaro Pagano, Ronald B. Postuma & Michael Lindemann
Neuroscience | Parkinson's Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
09:30 AM
Duration 15mins Virtual
Clinically meaningful change of motor symptoms and decline in daily life functioning in levodopa-treated patients with Parkinson´s Disease
Loes Rutten-Jacobs, Dylan Trundell, Annabelle Monnet, Nathalie Pross, Hanno Svoboda, Tania Nikolcheva, Gennaro Pagano
Neuroscience | Parkinson's Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
01:15 PM
Duration 15mins Virtual
CSF Pharmacokinetic and pharmacodynamics of semorinemab from a Phase 2 Trial in Prodromal-to-Mild Alzheimer's Disease (Tauriel)
Wildsmith KR, Toth B, Lee J, Ramakrishnan V, Dolton M, Brooks L, Schauer SP, Carrasco-Triguero M, Manser PT, Keeley M, Teng E
Neuroscience | Alzheimer Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
12:00 PM
Duration 45mins Virtual
Watch 'Parkinson’s. Time for meaningful change: looking back at symptomatic therapy and moving towards disease modification'
Anette Schrag, Rajeev Kumar, John Seibyl
Neuroscience | Parkinson's Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
11:15 AM
Duration 15mins Virtual
Benchmarking Disease Modifying Therapies for Alzheimer's Disease Using a Quantitative Systems Pharmacology Model
Ramakrishnan V, Friedrich C, Witt C, Sheehan R, Pryor M, Dolton M, Atwal J, Wildsmith K, Kudrycki K, Lee SH, Grimm HP, Aldea R, Mazer N, Hofmann C, Gieschke R, Fuji R, Ramanujan S, Quartino A, Jin JY
Neuroscience | Alzheimer Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.